DONGKOO BIO&PHARMA
DONGKOO BIO&PHARMA
Status:
Active
Technology used in webpage:
SSL By Default Apache GlobalSign CodeIgniter AlphaSSL LG U Plus
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-11-02 | Valted Seq | Dongkoo Bio&Pharma investment in Seed Round - Valted Seq | 10 M USD |
| 2018-07-18 | Neuraly | Dongkoo Bio&Pharma investment in Series A - Neuraly | 36 M USD |
| 2018-01-01 | D&D Pharmatech | Dongkoo Bio&Pharma investment in Series A - D&D Pharmatech | 36 M USD |
More informations about "Dongkoo Bio&Pharma"
DongKoo Bio&Pharma
We will contribute to a healthy and happy future life with trust, love and respect for life.See details»
DongKoo Bio&Pharma - Crunchbase Investor Profile
Dongkoo Bio&Pharma is a biopharmaceutical company that provides digestants, analgesics, and antipyretics. They provide products for nonsteroidal anti-inflammatory drugs, oral hypoglycemic agents, antiplatelet agents, …See details»
DongKoo Bio&Pharma
DongKoo Bio&Pharma is an innovative bio and pharmaceutical company extending its reach beyond the traditional pharmaceutical market to the stem cell-based healthcare market. Based on its principles of Responsibility, …See details»
DongKoo Bio & Pharma Company Description - Stock Analysis
Nov 21, 2024 The company was formerly known as DongKoo Pharm Co., Ltd. and changed its name to DongKoo Bio & Pharma Co., Ltd. in January 2014. The company was founded in …See details»
DongKoo Bio & Pharma - PitchBook
May 25, 2016 Dongkoo Bio&Pharma Co Ltd is engaged in the research, development, manufacture, and sale of pharmaceuticals products. The company provides products for digestants, other analgesics and antipyretics, …See details»
Dongkoo Bio&Pharma Company Profile - Craft
Oct 29, 2024 Dongkoo Bio&Pharma has 2 employees across 2 locations and â‚©215.69 b in annual revenue in FY 2023. See insights on Dongkoo Bio&Pharma including office locations, …See details»
Dongkoo Bio & Pharma Co.,Ltd. (South Korea) - EMIS
Jul 8, 2024 Dongkoo Bio & Pharma aims to become a total healthcare leader by encompassing prevention, diagnosis, treatment, and management. They prioritize R&D to strengthen their …See details»
Dongkoo Bio & Pharma Co Ltd - Company Profile and News
Company profile page for Dongkoo Bio & Pharma Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
Company DongKoo Bio & Pharma Co., Ltd. - MarketScreener.com
Dec 29, 2005 Business description: DongKoo Bio & Pharma Co., Ltd. Dongkoo Bio&Pharma Co.,Ltd. is a Korea-based company mainly engaged in the production and sale of …See details»
DongKoo Bio&Pharma Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for DongKoo Bio&Pharma Co., Ltd. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
DongKoo Bio & Pharma Co. Ltd. Company & People - Barron's
DongKoo Bio & Pharma Co. Ltd. company and executive profile by Barron's. View the latest 006620 company infomation and executive bios.See details»
DongKoo Bio&Pharma - Overview, News & Similar companies
Nov 5, 2020 'CELL BLOOM' cosmetics by Korean skin experts DongKoo Bio&Pharma to return at Cosmoprof Asia during Digital Week HONG KONG, Nov. 5, 2020 /PRNewswire/ -- Well …See details»
DongKoo Bio & Pharma Co. Ltd. - MarketWatch
006620 | Complete DongKoo Bio & Pharma Co. Ltd. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.See details»
DongKoo Bio signs MOU to move into SE Asian healthcare market
Jan 26, 2023 DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, the largest p ... "To take on …See details»
DongKoo Bio & Pharma Co. Ltd. - BioCentury Company Profiles
Jul 20, 2018 DongKoo Bio & Pharma Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
006620 | DongKoo Bio & Pharma Co. Ltd. Profile | MarketWatch
DongKoo Bio & Pharma Co. Ltd. company facts, information and financial ratios from MarketWatch.See details»
DongKoo Bio&Pharma - Investments, Portfolio & Company Exits
DongKoo Bio&Pharma has invested in Valted Seq on Jul 18, 2023. This investment - Seed Round - Valted Seq - was valued at . obfuscated. obfuscated. Announced Date ... Which industries …See details»
DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620) - Stock Analysis
About DongKoo Bio & Pharma. DongKoo Bio & Pharma Co., Ltd. manufactures and sells pharmaceuticals in South Korea. The company provides prescription drugs, such as …See details»
DongKoo Bio&Pharma - Contacts, Employees, Board Members
DongKoo Bio&Pharma has 1 current employee profile, CEO Yong Jun. Contacts. Edit Contacts Section. Job Department. Protected Content. Team Manager. Manager Operations. 1 email …See details»
Dongkoo Bio & Pharma Co Ltd - KOSDAQ - Bloomberg
Nov 25, 2024 Stock analysis for Dongkoo Bio & Pharma Co Ltd (006620:KOSDAQ) including stock price, stock chart, company news, key statistics, fundamentals and company profile.See details»